01/06/2025
7:15 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:11 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:12 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:32 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:25 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/08/2024
5:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
5:13 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
12:54 PM | VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
5:31 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:48 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:37 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
6:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:28 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:09 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
11:26 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024
8:20 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
8:21 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:29 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
6:23 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
6:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:11 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:13 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:00 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:47 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
7:03 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:38 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:55 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:56 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:58 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
07/24/2024
3:10 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
6:10 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024
6:54 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:33 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
7:51 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:04 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
8:27 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:02 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024
7:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:51 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:08 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
6:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:54 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:52 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024
6:04 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
